Daclizumab and Sirolimus to Treat Uveitis - Related Studies

Daclizumab and Sirolimus to Treat Uveitis

This study has been completed.

Study NCT00078689. Last updated on July 19, 2008. Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Uveitis

2	More general conditions related to this trial
		Eye Diseases
		Uveal Diseases

3	Interventions listed in this trial
		Daclizumab

4	Additional drug interventions recognized in this trial
		Sirolimus

5	More general drug interventions related to this trial
		Anti-Bacterial Agents
		Anti-Infective Agents
		Antibiotics, Antineoplastic
		Antifungal Agents
		Antineoplastic Agents
		Immunologic Factors
		Immunosuppressive Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

6	Sponsors listed in this trial
		National Eye Institute (NEI)